mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland

Intensive Care Med. 2022 Mar;48(3):362-365. doi: 10.1007/s00134-021-06610-z. Epub 2022 Jan 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Critical Illness
  • Humans
  • Intensive Care Units
  • RNA, Messenger
  • SARS-CoV-2*
  • Severity of Illness Index
  • Switzerland
  • Vaccination

Substances

  • COVID-19 Vaccines
  • RNA, Messenger